Hikma Pharmaceuticals Plc

(OTC) HKMPF

Current Price$18.10

Market Cap$3.90B

Since IPO (2007)+161%

5 Year-37%

1 Year-28%

1 Month+5%

Hikma Pharmaceuticals Plc Financials at a Glance

Market Cap

$3.90B

Revenue (TTM)

$6.49B

Net Income (TTM)

$761.99M

EPS (TTM)

$1.82

P/E Ratio

9.95

Dividend

$0.84

Beta (Volatility)

0.28 (Low)

Dividend

$0.84

Beta (Volatility)

0.28 (Low)

Price

$18.10

Volume

2,866

Open

$18.10

Price

$18.10

Volume

2,866

Open

$18.10

Previous Close

$18.10

Daily Range

$18.10 - $18.10

52-Week Range

$16.34 - $27.96

Dividend

$0.84

Beta (Volatility)

0.28 (Low)

Price

$18.10

Volume

2,866

Open

$18.10

Previous Close

$18.10

Daily Range

$18.10 - $18.10

52-Week Range

$16.34 - $27.96

HKMPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hikma Pharmaceuticals Plc

Industry

Pharmaceuticals

Sector

Health Care

Employees

9,400

CEO

Riad Mishlawi

Website

www.hikma.com

Headquarters

London, W1S 2HR, GB

HKMPF Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

17%

Net Income Margin

12%

Return on Equity

16%

Return on Capital

13%

Return on Assets

Earnings Yield

10.05%

Dividend Yield

4.64%

Payout Ratio

45.16%

Stock Overview

Market Cap

$3.90B

Shares Outstanding

215.23M

Volume

2.87K

Avg. Volume

657.476

Financials (TTM)

Gross Profit

$1.37B

Operating Income

$637.88M

EBITDA

$854.59M

Operating Cash Flow

$366.98M

Capital Expenditure

$201.38M

Free Cash Flow

$165.60M

Cash & ST Invst.

$354.57M

Total Debt

$1.65B

Hikma Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.70B

+17.5%

Gross Profit

$674.05M

-2.6%

Gross Margin

39.62%

N/A

Market Cap

$3.90B

N/A

Market Cap/Employee

$410.06K

N/A

Employees

9,500

N/A

Net Income

$164.99M

+179.6%

EBITDA

$411.47M

+19.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.30B

-34.8%

Accounts Receivable

$1.08B

+37.0%

Inventory

$1.11B

+24.3%

Long Term Debt

$1.54B

+49.3%

Short Term Debt

$114.18M

-29.1%

Return on Assets

7.10%

N/A

Return on Invested Capital

13.38%

N/A

Free Cash Flow

$101.68M

-66.2%

Operating Cash Flow

$229.22M

-40.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FLMNFFielmann AG

FLMNFFielmann AG$50.75+0.00%

DNPUFSumitomo Pharma Co., Ltd.

DNPUFSumitomo Pharma Co., Ltd.$11.43-1.47%

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited$2.34+0.00%

OPHLFOno Pharmaceutical Co., Ltd.

OPHLFOno Pharmaceutical Co., Ltd.$14.55+0.00%

OPHLYOno Pharmaceutical Co., Ltd.

OPHLYOno Pharmaceutical Co., Ltd.$4.86-1.12%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

NVDANvidia

NVDANvidia$198.45-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

AAPLApple

AAPLApple$280.14+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

Questions About HKMPF

What is the current price of Hikma Pharmaceuticals Plc?

Hikma Pharmaceuticals Plc is trading at $18.10 per share.

What is the 52-week range for Hikma Pharmaceuticals Plc?

Over the past 52 weeks, Hikma Pharmaceuticals Plc has traded between $16.34 and $27.96.

How much debt does Hikma Pharmaceuticals Plc have?

As of the most recent reporting period, Hikma Pharmaceuticals Plc reported total debt of $1.60B.

How much cash does Hikma Pharmaceuticals Plc have on hand?

Hikma Pharmaceuticals Plc reported $328.00M in cash and cash equivalents in its most recent financial results.

What is Hikma Pharmaceuticals Plc’s dividend yield?

Hikma Pharmaceuticals Plc currently has a dividend yield of 4.64%.

Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc Financials at a Glance

HKMPF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hikma Pharmaceuticals Plc

HKMPF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hikma Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HKMPF

What is the current price of Hikma Pharmaceuticals Plc?

What is the 52-week range for Hikma Pharmaceuticals Plc?

How much debt does Hikma Pharmaceuticals Plc have?

How much cash does Hikma Pharmaceuticals Plc have on hand?

What is Hikma Pharmaceuticals Plc’s dividend yield?

Premium Investing Services